SCOPUS 정보 검색 플랫폼

Volumn 7, Issue 6, 2001, Pages 1743-1749

Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer

(9) Konecny, Gottfried a Untch, Michael b Pihan, Astrid b Kimmig, Rainer b Gropp, Martina b Stieber, Petra c Hepp, Herrmann b Slamon, Dennis a Pegram, Mark a

a UNIVERSITY OF CALIFORNIA (United States)

b Departments of Obstetrics and Gynecology (United Kingdom)

c LUDWIG MAXIMILIANS UNIVERSITY (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; METASTASIS; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGNOSIS; RECURRENCE; TIME FACTORS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0034901514 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (84)

References (30)

1
- 0028944106
- Molecular insights into cancer invasion: Strategies for prevention and intervention
- (1995) Cancer Res. , vol.55 , pp. 1856-1862
- Kohn, E.C.¹ Liotta, L.A.²

2
- 0017309729
- Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture
- (1976) Nature (Lond.) , vol.261 , pp. 595-597
- Astedt, B.¹ Holmberg, L.²

3
- 0021780949
- Plasminogen activators, tissue degradation, and cancer
- (1985) Adv. Cancer Res. , vol.44 , pp. 139-266
- Dano, K.¹ Andreasen, P.A.² Grondahl-Hansen, J.³ Kristensen, P.⁴ Nielsen, L.S.⁵ Skriver, L.⁶

4
- 0030857717
- Clinical impact of the plasminogen activation system in tumor invasion and metastasis: Prognostic relevance and target for therapy
- (1997) Thromb. Haemost. , vol.78 , pp. 285-296
- Schmitt, M.¹ Harbeck, N.² Thomssen, C.³ Wilhelm, O.⁴ Magdolen, V.⁵ Reuning, U.⁶ Ulm, K.⁷ Hofler, H.⁸ Jänicke, F.⁹ Graeff, H.¹⁰

5
- 0029257171
- Urokinase/urokinase receptor system: Internalization/degradation of urokinase-serpin complexes: Mechanism and regulation
- (1995) Biol. Chem. Hoppe Seyler , vol.376 , pp. 143-155
- Conese, M.¹ Blasi, F.²

6
- 0025130717
- Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells
- (1990) Proc. Natl. Acad. Sci. USA , vol.87 , pp. 6939-6943
- Cajot, J.F.¹ Bamat, J.² Bergonzelli, G.E.³ Kruithof, E.K.⁴ Medcalf, R.L.⁵ Testuz, J.⁶ Sordat, B.⁷

7
- 0023735157
- Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report
- (1988) Cancer (Phila.) , vol.62 , pp. 531-533
- Duffy, M.J.¹ O'Grady, P.² Devaney, D.³ O'Siorain, L.⁴ Fennelly, J.J.⁵ Lijnen, H.J.⁶

8
- 0026440080
- Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients
- (1992) Cancer Res. , vol.52 , pp. 6101-6105
- Foekens, J.A.¹ Schmitt, M.² Van Putten, W.L.³ Peters, H.A.⁴ Bontenbal, M.⁵ Jänicke, F.⁶ Klijn, J.G.⁷

9
- 0024428950
- Urokinase-type plasminogen activator antigen and early relapse in breast cancer
- (1989) Lancet , vol.2 , pp. 1049
- Jänicke, F.¹ Schmitt, M.² Ulm, K.³ Gossner, W.⁴ Graeff, H.⁵

10
- 0028070859
- Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue
- (1994) Cancer Res. , vol.54 , pp. 4671-4675
- Pedersen, H.¹ Brunner, N.² Francis, D.³ Osterlind, K.⁴ Ronne, E.⁵ Hansen, H.H.⁶ Dano, K.⁷ Grondahl-Hansen, J.⁸

11
- 0027935805
- Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer
- (1994) Cancer Res. , vol.54 , pp. 4065-4071
- Ganesh, S.¹ Sier, C.F.² Griffioen, G.³ Vloedgraven, H.J.⁴ De Boer, A.⁵ Welvaart, K.⁶ Van de Velde, C.J.⁷ Van Krieken, J.H.⁸ Verheijen, J.H.⁹ Lamers, C.B.¹⁰

12
- 0029898212
- Clinical relevance of urokinase plasminogen activator, its receptor, and its inhibitor in patients with renal cell carcinoma
- (1996) Cancer (Phila.) , vol.78 , pp. 487-492
- Hofmann, R.¹ Lehmer, A.² Buresch, M.³ Hartung, R.⁴ Ulm, K.⁵

13
- 23444452203
- Tumour-associated proteolytic factors uPA and PAI-1 and survival in totally resected gastric cancer
- (1994) Lancet , vol.343 , pp. 117
- Nekarda, H.¹ Siewert, J.R.² Schmitt, M.³ Ulm, K.⁴

14
- 0028656476
- Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy
- (1994) Gynecol. Oncol. , vol.55 , pp. 401-409
- Kuhn, W.¹ Pache, L.² Schmalfeldt, B.³ Dettmar, P.⁴ Schmitt, M.⁵ Jänicke, F.⁶ Graeff, H.⁷

15
- 0028077218
- Plasminogen activators and plasminogen activator inhibitors in blood and tumor fluids of patients with ovarian cancer
- (1994) Eur. J. Cancer , vol.30 A , pp. 1302-1311
- Casslén, B.¹ Bossmar, T.² Lelander, I.³ Astedtm, B.⁴

16
- 0030464253
- Expression of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in benign, borderline, malignant primary, and metastatic ovarian tumors
- (1996) Int. J. Cancer , vol.69 , pp. 475-479
- Van der Burg, M.E.¹ Henzen-Logmans, S.C.² Berns, E.M.³ Van Putten, W.L.⁴ Klijn, J.G.⁵ Foekens, J.A.⁶

17
- 0031692103
- Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients
- (1998) Int. J. Cancer , vol.79 , pp. 449-454
- Chambers, S.K.¹ Ivins, C.M.² Carcangiu, M.L.³

18
- 0033055316
- Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc
- (1999) Br. J. Cancer , vol.79 , pp. 1746-1751
- Kuhn, W.¹ Schmalfeldt, B.² Reuning, U.³ Pache, L.⁴ Berger, U.⁵ Ulm, K.⁶ Harbeck, N.⁷ Spathe, K.⁸ Dettmar, P.⁹ Hofler, H.¹⁰ Jänicke, F.¹¹ Schmitt, M.¹² Graeff, H.¹³

19
- 0033017371
- Urokinase and plasminogen activator-inhibitor (PAI-1) status in primary ovarian carcinomas and ovarian metastases compared to benign ovarian tumors as a function of histopathological parameters
- (1999) Clin. Chem. Lab. Med. , vol.37 , pp. 47-54
- Hoffmann, G.¹ Pollow, K.² Weikel, W.³ Stritimatter, H.J.⁴ Bach, J.⁵ Schaffrath, M.⁶ Knapstein, P.⁷ Melchert, F.⁸ Pollow, B.⁹

20
- 0028358771
- Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1
- (1994) Cancer Res. , vol.54 , pp. 2527-2530
- Jänicke, F.¹ Pache, L.² Schmitt, M.³ Ulm, K.⁴ Thomssen, C.⁵ Prechtl, A.⁶ Graeff, H.⁷

21
- 0022913569
- Estradiol receptors in human breast carcinomas assayed by use of monoclonal antibodies
- (1986) Clin. Chem. , vol.32 , pp. 1972-1974
- Duffy, M.J.¹ O'Siorain, L.² Waldron, B.³ Smith, C.⁴

22
- 33845382806
- Nonparametric estimation from incomplete observations
- (1958) J. Am. Stat. Assoc. , vol.53 , pp. 457-481
- Kaplan, E.L.¹ Meier, P.²

23
- 0028631938
- Management of epithelial ovarian tumors of low malignant potential
- (1994) Gynecol. Oncol. , vol.55 , pp. 52-61
- Trimble, C.L.¹ Trimble, E.L.²

24
- 0026620239
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: A Gynecologic Oncology Group study
- (1992) Gynecol. Oncol. , vol.47 , pp. 159-166
- Hoskins, W.J.¹ Bundy, B.N.² Thigpen, J.T.³ Omura, G.A.⁴

25
- 0027191373
- Impact of age on survival of patients with ovarian cancer
- (1993) Gynecol. Oncol. , vol.49 , pp. 236-239
- Markman, M.¹ Lewis, J.L.² Saigo, P.³ Hakes, T.⁴ Rubin, S.⁵ Jones, W.⁶ Reichman, B.⁷ Curtin, J.⁸ Barakat, R.⁹ Almadrones, L.¹⁰ Morrissey, T.¹¹ Hoskins, W.¹²

26
- 0025860057
- Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: The Gynecologic Oncology Group experience
- (1991) J. Clin. Oncol. , vol.9 , pp. 1138-1150
- Omura, G.A.¹ Brady, M.F.² Homesley, H.D.³ Yordan, E.⁴ Major, F.J.⁵ Buchsbaum, H.J.⁶ Park, R.C.⁷

27
- 0018864451
- Advanced ovarian cancer: Correlation of histologic grade with response to therapy and survival
- (1980) Cancer (Phila.) , vol.45 , pp. 572-581
- Ozols, R.F.¹ Garvin, A.J.² Costa, J.³ Simon, R.M.⁴ Young, R.C.⁵

28
- 0026783516
- Radical surgical procedure improves survival time in patients with recurrent ovarian cancer
- (1992) Cancer (Phila.) , vol.70 , pp. 2129-2136
- Jänicke, F.¹ Holscher, M.² Kuhn, W.³ Von Hugo, R.⁴ Pache, L.⁵ Siewert, J.R.⁶ Graeff, H.⁷

29
- 0027550662
- Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasiveness
- (1993) Bioessays , vol.15 , pp. 105-111
- Blasi, F.¹

30
- 0027283371
- Prevention of metastasis by inhibition of the urokinase receptor
- (1993) Proc. Natl. Acad. Sci. USA , vol.90 , pp. 5021-5025
- Crowley, C.W.¹ Cohen, R.L.² Lucas, B.K.³ Liu, G.⁴ Shuman, M.A.⁵ Levinson, A.D.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.